-
1
-
-
85031326158
-
Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014
-
Rhee C, Dantes R, Epstein L, et al: Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014. JAMA 2017; 318:1241-1299
-
(2017)
JAMA
, vol.318
, pp. 1241-1299
-
-
Rhee, C.1
Dantes, R.2
Epstein, L.3
-
3
-
-
67649945779
-
The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation
-
Jones AE, Trzeciak S, Kline JA: The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 2009; 37:1649-1654
-
(2009)
Crit Care Med
, vol.37
, pp. 1649-1654
-
-
Jones, A.E.1
Trzeciak, S.2
Kline, J.A.3
-
4
-
-
0023092594
-
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
-
Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40:373-383
-
(1987)
J Chronic Dis
, vol.40
, pp. 373-383
-
-
Charlson, M.E.1
Pompei, P.2
Ales, K.L.3
-
5
-
-
85069978615
-
Development and validation of the SPoT Sepsis (Shock Prevention on Triage) clinical decision rule
-
Reisner AT, Roberta C, Thorsen JE, et al: Development and validation of the SPoT Sepsis (Shock Prevention on Triage) clinical decision rule. Abstr. Acad Emerg Med 2015; 22:S43
-
(2015)
Abstr. Acad Emerg Med
, vol.22
, pp. S43
-
-
Reisner, A.T.1
Roberta, C.2
Thorsen, J.E.3
-
6
-
-
85009804040
-
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
-
Rhodes A, Evans LE, Alhazzani M, et al: Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med 2017; 45:1-67
-
(2017)
Crit Care Med
, vol.45
, pp. 1-67
-
-
Rhodes, A.1
Evans, L.E.2
Alhazzani, M.3
-
7
-
-
85051428207
-
Delay within the 3-hour Surviving Sepsis Campaign guideline on mortality for patients with severe sepsis and septic shock
-
Pruinelli L, Westra BL, Yadav P, et al: Delay within the 3-hour Surviving Sepsis Campaign guideline on mortality for patients with severe sepsis and septic shock. Crit Care Med 2018; 46:500-505
-
(2018)
Crit Care Med
, vol.46
, pp. 500-505
-
-
Pruinelli, L.1
Westra, B.L.2
Yadav, P.3
-
8
-
-
85064147269
-
Culturenegative septic shock compared with culture-positive septic shock: A retrospective cohort study
-
Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group
-
Kethireddy S, Bilgili B, Sees A, et al; Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group: Culturenegative septic shock compared with culture-positive septic shock: A retrospective cohort study. Crit Care Med 2018; 46:506-512
-
(2018)
Crit Care Med
, vol.46
, pp. 506-512
-
-
Kethireddy, S.1
Bilgili, B.2
Sees, A.3
-
9
-
-
85020468010
-
Time to treatment and mortality during mandated emergency care for sepsis
-
Seymour CW, Gesten F, Prescott HC, et al: Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 2017; 376:2235-2244
-
(2017)
N Engl J Med
, vol.376
, pp. 2235-2244
-
-
Seymour, C.W.1
Gesten, F.2
Prescott, H.C.3
-
11
-
-
84904734154
-
Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: Results from a guideline-based performance improvement program
-
Ferrer R, Martin-Loeches I, Phillips G, et al: Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: Results from a guideline-based performance improvement program. Crit Care Med 2014; 42:1749-1755
-
(2014)
Crit Care Med
, vol.42
, pp. 1749-1755
-
-
Ferrer, R.1
Martin-Loeches, I.2
Phillips, G.3
-
12
-
-
84947039569
-
The impact of timing of antibiotics on outcomes in severe sepsis and septic shock: A systematic review and meta-analysis
-
Sterling SA, Miller WR, Pryor J, et al: The impact of timing of antibiotics on outcomes in severe sepsis and septic shock: A systematic review and meta-analysis. Crit Care Med 2015; 43:1907-1915
-
(2015)
Crit Care Med
, vol.43
, pp. 1907-1915
-
-
Sterling, S.A.1
Miller, W.R.2
Pryor, J.3
-
13
-
-
0034675059
-
The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making
-
Antman EM, Cohen M, Bernink PJ, et al: The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000; 284:835-842
-
(2000)
JAMA
, vol.284
, pp. 835-842
-
-
Antman, E.M.1
Cohen, M.2
Bernink, P.J.3
-
14
-
-
13244256881
-
Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism
-
Kline JA, Mitchell AM, Kabrhel C, et al: Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. J Thromb Haemost 2004; 2:1247-1255
-
(2004)
J Thromb Haemost
, vol.2
, pp. 1247-1255
-
-
Kline, J.A.1
Mitchell, A.M.2
Kabrhel, C.3
-
15
-
-
85015825805
-
The absence of fever is associated with higher mortality and decreased antibiotic and IV fluid administration in emergency department patients with suspected septic shock
-
Henning DJ, Carey JR, Oedorf K, et al: The absence of fever is associated with higher mortality and decreased antibiotic and IV fluid administration in emergency department patients with suspected septic shock. Crit Care Med 2017; 45:e575-e582
-
(2017)
Crit Care Med
, vol.45
, pp. e575-e582
-
-
Henning, D.J.1
Carey, J.R.2
Oedorf, K.3
-
16
-
-
0033922252
-
Hypothermia and cytokines in septic shock. Norasept II Study Investigators. North American study of the safety and efficacy of murine monoclonal antibody to tumor necrosis factor for the treatment of septic shock
-
Marik PE, Zaloga GP: Hypothermia and cytokines in septic shock. Norasept II Study Investigators. North American study of the safety and efficacy of murine monoclonal antibody to tumor necrosis factor for the treatment of septic shock. Intensive Care Med 2000; 26:716-721
-
(2000)
Intensive Care Med
, vol.26
, pp. 716-721
-
-
Marik, P.E.1
Zaloga, G.P.2
-
18
-
-
85011301346
-
Fever in the emergency department predicts survival of patients with severe sepsis and septic shock admitted to the ICU
-
Sundén-Cullberg J, Rylance R, Svefors J, et al: Fever in the emergency department predicts survival of patients with severe sepsis and septic shock admitted to the ICU. Crit Care Med 2017; 45:591-599
-
(2017)
Crit Care Med
, vol.45
, pp. 591-599
-
-
Sundén-Cullberg, J.1
Rylance, R.2
Svefors, J.3
-
19
-
-
42949170034
-
Occurrence and outcome of fever in critically ill adults
-
Laupland KB, Shahpori R, Kirkpatrick AW, et al: Occurrence and outcome of fever in critically ill adults. Crit Care Med 2008; 36:1531-1535
-
(2008)
Crit Care Med
, vol.36
, pp. 1531-1535
-
-
Laupland, K.B.1
Shahpori, R.2
Kirkpatrick, A.W.3
-
20
-
-
84887370742
-
The impact of body temperature abnormalities on the disease severity and outcome in patients with severe sepsis: An analysis from a multicenter, prospective survey of severe sepsis
-
JAAM Sepsis Registry Study Group
-
Kushimoto S, Gando S, Saitoh D, et al; JAAM Sepsis Registry Study Group: The impact of body temperature abnormalities on the disease severity and outcome in patients with severe sepsis: An analysis from a multicenter, prospective survey of severe sepsis. Crit Care 2013; 17:R271
-
(2013)
Crit Care
, vol.17
, pp. R271
-
-
Kushimoto, S.1
Gando, S.2
Saitoh, D.3
-
21
-
-
84862508904
-
Early peak temperature and mortality in critically ill patients with or without infection
-
Young PJ, Saxena M, Beasley R, et al: Early peak temperature and mortality in critically ill patients with or without infection. Intensive Care Med 2012; 38:437-444
-
(2012)
Intensive Care Med
, vol.38
, pp. 437-444
-
-
Young, P.J.1
Saxena, M.2
Beasley, R.3
-
22
-
-
84940743799
-
Septic shock: Advances in diagnosis and treatment
-
Seymour CW, Rosengart MR: Septic shock: Advances in diagnosis and treatment. JAMA 2015; 314:708-717
-
(2015)
JAMA
, vol.314
, pp. 708-717
-
-
Seymour, C.W.1
Rosengart, M.R.2
-
23
-
-
84959161804
-
Immune cell phenotype and function in sepsis
-
ADQI XIV Workgroup
-
Rimmelé T, Payen D, Cantaluppi V, et al; ADQI XIV Workgroup: Immune cell phenotype and function in sepsis. Shock 2016; 45:282-291
-
(2016)
Shock
, vol.45
, pp. 282-291
-
-
Rimmelé, T.1
Payen, D.2
Cantaluppi, V.3
-
24
-
-
84959273475
-
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
-
Singer M, Deutschman CS, Seymour CW, et al: The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315:801-810
-
(2016)
JAMA
, vol.315
, pp. 801-810
-
-
Singer, M.1
Deutschman, C.S.2
Seymour, C.W.3
-
25
-
-
84959317195
-
Assessment of clinical criteria for sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
-
Seymour CW, Liu VX, Iwashyna TJ, et al: Assessment of clinical criteria for sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315:762-774
-
(2016)
JAMA
, vol.315
, pp. 762-774
-
-
Seymour, C.W.1
Liu, V.X.2
Iwashyna, T.J.3
|